NHS Transformation Unit and Cheshire & Merseyside Cancer Alliance is shortlisted as a finalist for the HSJ Partnership Awards 2023
NHS Transformation Unit and Cheshire & Merseyside Cancer Alliance are delighted to announce that the Gynaecological Cancer Services Review in Cheshire & Merseyside has been shortlisted for Most Effective Contribution to Clinical Redesign at the HSJ Partnership Awards 2023, recognising the outstanding dedication to improving healthcare and effective collaboration with the NHS.
The national healthcare sector faced innumerable pressures over the past 12 months – yet the standard and overriding positivity of the partnerships this year highlight the enduring dedication to improving patient outcomes.
Being shortlisted for a HSJ Partnership Award has given the teams an opportunity to celebrate the important work delivered so far to improve gynaecological cancer services in Cheshire and Merseyside.
The HSJ Partnership Awards recognise and honour the most effective partnerships, innovative projects and collaborations in the UK health system. The prestigious award programme, now in its sixth year, is not just a celebration of success stories but also a platform to shape the future of the new integrated health and care system.
The judging panel comprised a diverse range of highly regarded figures across the NHS and wider healthcare sector. To be shortlisted as a finalist for these awards, despite tough competition from a pool of brilliant applications, is a mark of real achievement for NHS Transformation Unit and Cheshire & Merseyside Cancer Alliance. The Gynaecological Cancer Services Review in Cheshire & Merseyside has been selected based on the project team’s diligence, ambition, and the positive impact that the project has had on both practitioners and patients within the health care industry.
Cheshire & Merseyside Cancer Alliance commissioned the NHS Transformation Unit to undertake an end-to-end pathway review across all gynaecological cancer services. The aim was to develop a detailed understanding of current service provision, working with partners to develop a vision to achieve excellent services for the future; underpinning this with recommendations and a plan to realise this ambition.
More than 100 stakeholders participated across more than 15 organisations via visits to cancer units, diagnostic teams and specialist centres, 1:1 meetings, surveys and workshops across 15 organisations. The review was driven forward by CMCA, the TU and the co-clinical leadership of Dawn Valentine-Gray and Mr John Kirwan (both of Liverpool Women’s NHS Foundation Trust), with support for a working group with membership across Cheshire & Merseyside. This culminated in a full day event where findings and recommendations were presented, with a shared vison for gynaecological cancer services being developed and agreed. This review has formed the basis for a large-scale transformation programme across all gynaecological cancer services to deliver the agreed partnership model of care. The programme is delivering a wide range of initiatives across workforce, screening, diagnostics, treatment and follow up care. Learning from the work has been shared across UK-wide networks and programmes.
Sarah Maynard-Walker, Managing Consultant at NHS Transformation Unit, comments:
“We are delighted to have been shortlisted for Most Effective Contribution to Clinical Redesign, recognising the collaborative efforts and dedication of our team to successfully deliver the Gynaecological Cancer Services Review in Cheshire & Merseyside. We are committed to delivering improved outcomes for patients, and to be chosen among the other incredible nominees is a wonderful achievement. This nomination has been a tremendous boost to both to our team and our NHS partner at Cheshire & Merseyside Cancer Alliance and I am sure it will bolster our continued efforts to support transformative clinical service redesign.”
Anna Murray, Senior Programme Manager at Cheshire and Merseyside Cancer Alliance said:
“The review was initiated based on feedback from patients and a review of cancer performance data. This highlighted the clear need for gynaecological cancer services to become a priority for review and improvement. What started as an idea has translated into a large-scale programme of change across all gynaecology services in Cheshire and Merseyside. The on-going success of this programme is testament to the hard work of members of the Alliance team, our organisational partners, and our patient and clinical leaders across Cheshire and Merseyside. Delivery of the review and the establishment of the ambitious change programme would not have been possible without the fantastic support of the NHS Transformation Unit and an appetite for improvement and collaboration across organisations with Cheshire & Merseyside.”
HSJ editor Alastair McLellan comments:
“We would like to congratulate NHS Transformation Unit and Cheshire & Merseyside Cancer Alliance on being nominated in the category of Most Effective Contribution to Clinical Redesign ahead of HSJ Partnership Awards 2023. We are looking forward to welcoming them to the ceremony in March, to join us in recognising the very best collaborations and innovations in the healthcare sector. This year’s finalists are of an outstanding calibre and all of them are exceptionally dedicated to enhancing healthcare across the UK.”
The winners will be selected following a rigorous judging stage ahead of the HSJ Partnership Awards 2023 awards ceremony. The awards evening is expected to be attended by national healthcare leaders and professionals from both the NHS and private sector as well as figures from non-clinical backgrounds to celebrate innovation and collaboration in healthcare.
The full list of nominees for the 2023 HSJ Partnership Awards can be found at https://partnership.hsj.co.uk/finalists-2023/
The selected winners will be announced during a private ceremony at Evolution London, on 23 March 2023.